Cabergoline therapy for Macroprolactinoma during pregnancy: A case report
نویسندگان
چکیده
منابع مشابه
replacement therapy for gaucher disease during pregnancy: a case report
background: gaucher disease is a lysosomal storage disorder due to deficiency of glucocerebrosidase enzyme. in this study, a case of enzyme-treated woman during her pregnancy was reported. case presentation: a 27-year old woman with type i gaucher disease was managed for pregnancy until delivery. she underwent elective splenectomy at age 26 years and was treated with 19-38 units/kg of imiglucer...
متن کاملPneumocephalus during cabergoline treatment of an invasive macroprolactinoma.
A 43-year-old male trisomic patient was referred for acute left headache and progressive homolateral mydriasis and ptosis. Computed tomography and T2-magnetic resonance imaging demonstrated a 4 cm invasive pituitary adenoma (Panels A and C, respectively). Blood analyses revealed hyperprolactinemia (5460 ng/ml, normal values < 15 ng/ml) and severe gonadotrophic insuffi ciency. Treatment was clas...
متن کاملAnesthetic care for electroconvulsive therapy during pregnancy -A case report-
Electroconvulsive therapy (ECT) is recommended for patients with psychotic disorders that do not respond to medication. Usually, many psychotropic medications have teratogenic effects on the fetus. ECT seems to be a relatively safe and effective treatment during pregnancy. We report here on a 33-year-old primigravida patient in her third trimester receiving ECT.
متن کاملReplacement Therapy for Gaucher Disease during Pregnancy: A Case Report
BACKGROUND Gaucher disease is a lysosomal storage disorder due to deficiency of glucocerebrosidase enzyme. In this study, a case of enzyme-treated woman during her pregnancy was reported. CASE PRESENTATION A 27-year old woman with type I Gaucher disease was managed for pregnancy until delivery. She underwent elective splenectomy at age 26 years and was treated with 19-38 units/kg of imiglucer...
متن کاملCabergoline for Cushing's disease: A case report.
como la mayor dosificación (> 400 mg/día) podría favorecer la aparición de un síndrome de Cushing11. En consecuencia, debe tenerse especial precaución al utilizar AM por su acción sobre el eje del cortisol, dada la posibilidad de producirse, en un mismo paciente, un síndrome de Cushing y una IS posterior al retirar el AM bruscamente12. En conclusión, dado que el AM es un fármaco comúnmente util...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Research Notes
سال: 2012
ISSN: 1756-0500
DOI: 10.1186/1756-0500-5-606